DEA Receives Importer Application From Norac Pharma
February 13, 2026
February 13, 2026
WASHINGTON, Feb. 13 (TNSFR) -- The U.S. Department of Justice Drug Enforcement Administration announced that S&B Pharma LLC dba Norac Pharma, Azusa, California, has applied for registration as an importer of specific controlled substances.
According to the federal notice, the company intends to import the following Schedule II substances:
* 4-Anilino-N-phenethyl-4-piperidine (ANPP)
* Tapentadol
The applicant plans to use intermediate forms . . .
According to the federal notice, the company intends to import the following Schedule II substances:
* 4-Anilino-N-phenethyl-4-piperidine (ANPP)
* Tapentadol
The applicant plans to use intermediate forms . . .